Fitaro Inj 0.25 mg
Semaglutide
Fitaro Inj 0.25 mg supports blood sugar control in type 2 diabetes by enhancing insulin release and reducing glucose production from the liver.
- Strengths 0.25
- Form Injection
- Packaging Size 120 IU/ml
- Packaging Type Box
- Manufacturer Incepta Pharmaceuticals Ltd
Description of Fitaro Inj 0.25 mg
Fitaro Inj 0.25 mg contains Semaglutide, a GLP-1 receptor agonist that mimics the action of incretin hormones. It helps regulate blood sugar in adults with type 2 diabetes by stimulating insulin release after meals and reducing the amount of sugar produced by the liver. Fitaro Inj also slows gastric emptying, aiding in better appetite control and weight management. Though not a substitute for insulin, it complements diet and lifestyle adjustments to maintain optimal glucose levels. It is administered once weekly under medical guidance for effective and sustained glycaemic control.
Ingredients of Fitaro Inj 0.25 mg
- Active Ingredient: Semaglutide 0.25 mg
- Inactive Ingredients: Water for injection, buffering agents
Usage of Fitaro Inj 0.25 mg
- Inject once weekly, same day each week
- Administer subcutaneously in abdomen, thigh, or upper arm
- Use under physician supervision
- Store in refrigerator (2°C–8°C), do not freeze
Precautions for Fitaro Inj 0.25 mg
- Not a replacement for insulin therapy
- Avoid use if you have medullary thyroid carcinoma history
- Inform doctor if pregnant or breastfeeding
- Monitor for signs of low blood sugar, especially if on other medications
- May cause nausea or digestive discomfort initially
More like this
Find related medicines from trusted suppliers. Explore similar products to ensure you get the right medication for your needs.
